Edward Hu

Edward Hu is the founder of 6 Dimensions Capital.
Current jobs include Vice Chairman & Global Chief Investment Officer at WUXI APPTEC, INC since 2017, Director at Callidus Biopharma, Inc., Director at Vivace Therapeutics, Inc., Director at Shanghai Syn-the-all Pharmaceutical Co. Ltd. since 2017, Director at PrecisioBiotix, Inc., Director at JW Biotechnology (Shanghai) Co. Ltd., Non-Executive Director at CStone Pharmaceuticals Co. Ltd. since 2021, Director at LifeMine Therapeutics, Inc., Director at Wuxi Biologics Holdings Ltd., Director at Wuxi New Life Science Investment Ltd., Director at WuXi Apptec UK Ltd. since 2018, and Director at Hua Medtech Medical Devices (Shanghai) Co., Ltd. since 2020.
Former jobs include Chief Executive Officer at WuXi Advanced Therapies, Inc., Vice Chairman & Chief Investment Officer at WuXi AppTec Co., Ltd. from 2007 to 2025, Director at Ambrx, Inc., Director at TenNor Therapeutics Suzhou Ltd., Director at IDEAYA Biosciences, Inc., Non-Executive Director at Wuxi Biologics (Cayman), Inc. from 2010 to 2021, Independent Director at Viela Bio, Inc. from 2018 to 2021, Director at JW Therapeutics (Shanghai) Co., Ltd., Director at Ambrx Biopharma Cayman, Inc. from 2022 to 2023, Director at Suzhou Borui Chuanghe Pharmaceutical Co., Ltd., Non-Executive Director at CANbridge Pharmaceuticals Inc. from 2022 to 2024, Senior Financial Analyst at Merck & Co., Inc. from 1996 to 1998, Manager-Financial Planning & Business Analysis at Biogen, Inc. in 2000, Chief Operating Officer & Senior Vice President at Tanox, Inc. from 2000 to 2007, and Chief Financial & Investment Officer at Wuxi PharmaTech (Cayman), Inc. from 2007 to 2015.
Education includes graduate and MBA degrees from Carnegie Mellon University in 1996 and an undergraduate degree from Zhejiang University in 1983.